Top Story

FDA approves Jadenu for chronic iron overload

March 31, 2015

The FDA announced the approval of Jadenu tablets for the treatment of certain patients with chronic iron overload, according to a press release from the drug’s manufacturer.

Jadenu (deferasirox, Novartis) is intended for patients aged 2 years or older with chronic iron overload due to repeated blood transfusions and patients aged 10 years or older with chronic iron overload due to non-transfusion-dependent thalassemia syndromes. Jadenu received accelerated approval for these indications based on reduction of liver iron concentration and serum ferritin levels.

Darius N. Lakdawalla, PhD In the Journals

Value of PFS as surrogate in NSCLC varies considerably

March 31, 2015
The value of providing access to new treatments for non–small cell lung cancer based on improvements in PFS varied according to incremental treatment cost, the…
Michael Boeckh In the Journals

Antivirals improve CMV pneumonia outcomes after HCT

March 30, 2015
Outcomes of cytomegalovirus pneumonia after hematopoietic cell transplantation have improved modestly over the past 25 years largely due to antiviral treatment and…
FDA News

FDA grants priority review for expanded use of Kyprolis in relapsed multiple myeloma

March 30, 2015
The FDA today accepted the supplemental new drug application of carfilzomib for the treatment of patients with relapsed multiple myeloma who have received at least one…
Dennis Slamon Industry News

Panel of cancer experts highlight advancements in precision medicine

March 30, 2015
Advancements in the understanding of cancer genetics have led to important breakthroughs in precision medicine, according to a Columbia University media briefing on the…
More News Headlines »
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
thumbnail for video 4126759064001

Solid organ transplant recipients at higher risk for skin cancer

March 22, 2015
SAN FRANCISCO – In this video, Sarah Tuttleton Arron, MD, PhD, FAAD, discusses her research on mortality from…
More »
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »